Gyros Protein Technologies provides enabling peptide synthesis and bioanalytical solutions helping scientists increase biomolecule performance and productivity in pre-clinical/clinical development and bioprocess applications. The automated Gyrolab® immunoassay platform and expanding portfolio of kits are used by companies in the development and manufacturing of biotherapies including cell and gene therapies.